1. Australia Stocks

  2. •

    Health services

  3. •

    Services to the health industry
Pro Medicus, Ltd.

Pro Medicus, Ltd.

107.06
EUR
0.00
(0.00%)
1.54EPS
78.48P/E
12.61BMarket Cap
Feb 16Next Earn
Pro Medicus, Ltd.
MUN:PMC
(Munich Stock Exchange)

Recent

price

107.06

P/E

ratio

78.48

div

yld

0.35%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
AUD
0.14
0.11
0.11
0.14
0.17
0.27
0.31
0.35
0.48
0.55
0.65
0.9
1.2
1.55
2.04
2.5
Revenue per Share
0.01
0.02
0.05
0.02
0.03
0.06
0.09
0.12
0.18
0.22
0.3
0.43
0.58
0.79
1.1
2.54
Basic EPS, GAAP
0.06
0.06
0.04
0.04
0.04
0.11
0.14
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
0.02
- -
0.02
0.02
0.02
0.02
0.03
0.05
0.1
0.11
0.13
0.18
0.25
0.35
0.47
0.62
Dividend per Share
0.15
0.16
0.21
0.21
0.22
0.27
0.34
0.44
0.48
0.58
0.78
0.98
1.33
1.8
2.46
4.32
Book Value per Share
0.14
0.15
0.21
0.21
0.22
0.27
0.19
0.28
0.3
0.4
0.59
0.76
1.12
1.61
2.26
4.1
Tangible Book Value per Share
100
100
100
100
100
101
102
103
104
104
104
104
104
104
104
104
Basic Weighted Avg Shares
14
11
11
14
17
28
32
36
50
57
68
93
125
161
213
262
Sales/Revenue/Turnover
9.28
0.68
-10.83
16.48
19.17
34.58
44.77
46.8
50.8
52.88
62.41
66.73
67.12
69.49
74.03
74.94
Operating Margin (%)
3
3
3
3
3
4
4
5
6
8
7
7
8
9
7
8
Depreciation Expense
1
2
5
2
3
6
9
13
19
23
31
44
61
83
115
265
Net Income, GAAP
28.14
25.81
- -
38.46
37.07
32.95
30.5
26.64
26.79
23.13
28.04
29.55
29.58
28.93
29.45
29.71
Effective Tax Rate (%)
3.6
15.92
46
10.59
18.42
23.16
29.54
35.48
38.19
40.64
45.48
47.58
48.6
51.29
54.12
101.42
Profit Margin (%)
3
6
14
13
13
17
23
28
47
63
70
93
133
173
237
306
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
2
1
2
2
1
LT Debt
15
16
21
21
22
27
35
46
49
60
82
102
139
188
257
451
Total Equity
5.63
0.35
- -
5.83
8.99
24.26
29.4
29.66
38.58
41.03
41.04
44.74
45.82
46.98
48.82
38.07
Return on Invested Capital (%)
3.14
11.48
- -
7.24
15.09
25.82
29.96
31.66
40.28
41.3
42.04
47.2
49.58
50.11
51.32
74.5
Return on Capital (%)
3.14
11.48
27.76
7.24
15.09
25.82
29.96
31.66
40.28
42.16
43.49
48.46
50.43
50.72
51.82
74.97
Return on Common Equity (%)

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.26%
41.72%
75.48%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
47.4%
57.3%
130.3%
Sales/Revenue/Turnover
25.63%
31.08%
22.88%
Total Cash Common Dividend
39.9%
36.78%
31.9%

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
161
2025
- -
- -
213
2026
- -
- -
262

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.79
2025
- -
- -
1.1
2026
- -
- -
2.54

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.35
2025
- -
- -
0.47
2026
- -
- -
0.62
Similar Companies
Quest Diagnostics Incorporated (NYSE:DGX)
Astrana Health Inc. (NASDAQ:ASTH)
NRC Health (NASDAQ:NRC)
teno.Holdings Co., Ltd. (TSE:7037)
Tameny, Inc. (TSE:6181)
Attendo AB (STO:ATT)
Business
Pro Medicus Limited (ASX:PME) is an Australia-based healthcare informatics company that develops and supplies medical imaging software and radiology information systems (RIS) to hospitals, imaging centers, and healthcare groups worldwide. The company offers a comprehensive suite of products and services, including Visage 7 Enterprise Imaging Platform, a cloud or on-premise solution providing ultrafast diagnostic imaging, clinical workflows, vendor-neutral archiving, and AI acceleration through its One Viewer philosophy; Visage RIS, featuring medical accounting, clinical reporting, appointment scheduling, and management information applications; Visage RIS/PACS for integrated radiology operations; and Visage Ease and Visage Ease Pro for mobile access to images and reports, including diagnostic capabilities; as well as services encompassing workflow optimization, network design, hardware configuration, staff training, and 24/7 support. Founded in 1983 and headquartered in Melbourne, Victoria, Pro Medicus operates primarily in Australia, North America, and Europe, with its wholly-owned subsidiary Visage Imaging delivering enterprise-scale PACS replacement solutions globally. In recent developments, the company reported full-year 2025 revenue of A$213.0 million, reflecting strong growth; secured a five-year A$44 million contract with Advanced Radiology Management for Visage 7 Enterprise in November 2025; signed multiple multi-year contracts in prior periods, such as a nine-year US$33 million partnership with the University of Kentucky; launched Visage Ease VP for Apple Vision Pro in February 2024; and continues to pursue mergers and acquisitions as stated by its chairman in November 2025.

Company News

Company News APIChatGPT

  • defenseworld.net

    Pro Medicus (OTCMKTS:PMCUF) versus DarioHealth (NASDAQ:DRIO) Head to Head Survey

  • seekingalpha.com

    Pro Medicus Limited (PMDIY) Q4 2026 Earnings Call Transcript

  • defenseworld.net

    Firefly Neuroscience (NASDAQ:AIFF) vs. Pro Medicus (OTCMKTS:PMCUF) Head-To-Head Analysis

  • seekingalpha.com

    Pro Medicus Limited (PMDIY) Q2 2026 Earnings Call Transcript

  • defenseworld.net

    Insider Buying: Pro Medicus (ASX:PME) Insider Acquires A$134,400.00 in Stock

  • defenseworld.net

    Pro Medicus (OTCMKTS:PMCUF) Shares Down 4% – Time to Sell?

  • seekingalpha.com

    Pro Medicus Limited (PMDIY) Shareholder/Analyst Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2025 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q2 2025 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2024 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q4 2023 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) Q2 2023 Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q4 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert On Q2 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert on Half Year 2022 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript

  • seekingalpha.com

    Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript